SCI时时刷

search
FGFR4-driven plasticity in breast cancer progression and resistance to therapy
FGFR4-driven plasticity in breast cancer progression and resistance to therapy
Breast cancer (BCa) is a complex and heterogeneous disease, with different intrinsic molecular subtypes that have distinct...
Radiation Reveal: Moving from research engagement to involvement
Radiation Reveal: Moving from research engagement to involvement
Here, we report on the process of a highly impactful and successful creative, collaborative, and multi-partner public enga...
Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma
Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma
Chordomas are rare osseous neoplasms with a dismal prognosis when they recur. Here we identified cell surface proteins tha...
Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
Previous studies have suggested that patients with HER2-low breast cancers do not benefit from trastuzumab treatment altho...
The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers
The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers
Other than for breast cancer, endocrine therapy has not been highly effective for gynecologic cancers. Endocrine therapy r...
GCN5 mediates DNA-PKcs crotonylation for DNA double-strand break repair and determining cancer radiosensitivity
GCN5 mediates DNA-PKcs crotonylation for DNA double-strand break repair and determining cancer radiosensitivity
DNA double-strand break (DSB) induction and repair are important events for determining cell survival and the outcome of c...
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION
Tepotinib, a MET inhibitor approved for the treatment of MET exon 14 (METex14) skipping NSCLC, demonstrated durable clinic...
Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
Menopausal hormone therapy (MHT), a common treatment to relieve symptoms of menopause, is associated with a lower risk of ...
Oesophageal cancer awareness and anticipated time to help-seeking: results from a population-based survey
Oesophageal cancer awareness and anticipated time to help-seeking: results from a population-based survey
Modifying public awareness of oesophageal cancer symptoms might help to decrease late-stage diagnosis and, in turn, improv...
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
Reducing nivolumab dose intensity could increase patients’ life quality and decrease the financial burden while main...
Identification of unique rectal cancer-specific subtypes
Identification of unique rectal cancer-specific subtypes
Existing colorectal cancer subtyping methods were generated without much consideration of potential differences in express...
Radiation therapy with phenotypic medicine: towards N-of-1 personalization
Radiation therapy with phenotypic medicine: towards N-of-1 personalization
In current clinical practice, radiotherapy (RT) is prescribed as a pre-determined total dose divided over daily doses (fra...
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
More than half of mesothelioma tumours show alterations in the tumour suppressor gene BAP1. BAP1-deficient mesothelioma is...
Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy
These authors contributed equally: Q. Tan, A. M. Joshua.Department of Medical Biophysics, University Health Network, Unive...